$PMDI
PSYCHEMEDICS CORP Stock $pmdi

$pmdi Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000117184322007389 Filed on November 10, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$5.703M	$6.516M
YoY Change	-11.39%	-2.35%
Cost Of Revenue	$3.458M	$4.184M
YoY Change	-18.65%	16.29%
Gross Profit	$2.245M	$2.332M
YoY Change	2.75%	-24.16%
Gross Profit Margin	39.37%	35.79%
Selling, General & Admin	$2.278M	$2.379M
YoY Change	-19.7%	20.09%
% of Gross Profit	101.47%	102.02%
Research & Development	$323.0K	$328.0K
YoY Change	3.19%	34.43%
% of Gross Profit	14.39%	14.07%
Depreciation & Amortization	$531.0K	$597.0K
YoY Change	-18.31%	-23.56%
% of Gross Profit	23.65%	25.6%
Operating Expenses	$2.601M	$2.707M
YoY Change	-17.43%	21.66%
Operating Profit	-$356.0K	-$375.0K
YoY Change	-63.11%	-144.12%
Interest Expense	-$6.000K	-$8.000K
YoY Change	-64.71%	-33.33%
% of Operating Profit
Other Income/Expense, Net		-$8.000K
YoY Change		-110.67%
Pretax Income	-$362.0K	-$383.0K
YoY Change	-82.4%	-141.41%
Income Tax	$326.0K	-$286.0K
% Of Pretax Income
Net Earnings	-$688.0K	-$97.00K
YoY Change	-57.56%	-113.13%
Net Earnings / Revenue	-12.06%	-1.49%
Basic Earnings Per Share		-$0.02
Diluted Earnings Per Share	-$0.12	-$0.02
COMMON SHARES
Basic Shares Outstanding	5.645M	5.626M
Diluted Shares Outstanding		5.638M

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.750M	$3.458M
YoY Change	138.45%	75.71%
Cash & Equivalents	$4.750M	$3.500M
Short-Term Investments
Other Short-Term Assets	$1.136M	$1.510M
YoY Change	-24.22%	-45.17%
Inventory
Prepaid Expenses
Receivables	$3.739M	$4.953M
Other Receivables	$339.0K	$803.0K
Total Short-Term Assets	$9.964M	$10.72M
YoY Change	-3.12%	-8.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.254M	$7.976M
YoY Change	8.41%	9.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.514M	$843.0K
YoY Change	75.23%	-4.53%
Total Long-Term Assets	$8.768M	$9.754M
YoY Change	-22.18%	-18.45%
TOTAL ASSETS
Total Short-Term Assets	$9.964M	$10.72M
Total Long-Term Assets	$8.768M	$9.754M
Total Assets	$18.73M	$20.48M
YoY Change	-13.08%	-13.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$448.0K	$857.0K
YoY Change	-54.93%	91.29%
Accrued Expenses	$4.976M	$3.974M
YoY Change	56.09%	23.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$294.0K	$360.0K
YoY Change	-55.72%	-48.28%
Total Short-Term Liabilities	$5.718M	$6.176M
YoY Change	-1.92%	15.61%
LONG-TERM LIABILITIES
Long-Term Debt	$305.0K	$380.0K
YoY Change	-49.08%	-48.65%
Other Long-Term Liabilities	$1.938M	$2.200M
YoY Change	-32.71%	-31.97%
Total Long-Term Liabilities	$2.243M	$380.0K
YoY Change	274.46%	-48.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.718M	$6.176M
Total Long-Term Liabilities	$2.243M	$380.0K
Total Liabilities	$7.961M	$8.756M
YoY Change	-14.48%	-8.85%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.82M	-$10.73M
YoY Change	23.77%	40.3%
Common Stock	$34.31M	$34.17M
YoY Change	2.38%	2.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.08M	$10.08M
YoY Change	0.0%	0.0%
Treasury Stock Shares	$668.0K	$668.0K
Shareholders Equity	$10.77M	$11.72M
YoY Change
Total Liabilities & Shareholders Equity	$18.73M	$20.48M
YoY Change	-13.08%	-13.35%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$688.0K	-$97.00K
YoY Change	-57.56%	-113.13%
Depreciation, Depletion And Amortization	$531.0K	$597.0K
YoY Change	-18.31%	-23.56%
Cash From Operating Activities	$1.894M	$2.334M
YoY Change	235.22%	-701.55%
INVESTING ACTIVITIES
Capital Expenditures	$24.00K	-$91.00K
YoY Change	-180.0%	33.82%
Acquisitions
YoY Change
Other Investing Activities	$4.000K	-$7.000K
YoY Change	0.0%	-86.0%
Cash From Investing Activities	-$20.00K	-$98.00K
YoY Change	-23.08%	-16.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-582.0K	-568.0K
YoY Change	13.01%	220.9%
NET CHANGE
Cash From Operating Activities	1.894M	2.334M
Cash From Investing Activities	-20.00K	-98.00K
Cash From Financing Activities	-582.0K	-568.0K
Net Change In Cash	1.292M	1.668M
YoY Change	5283.33%	-344.22%
FREE CASH FLOW
Cash From Operating Activities	$1.894M	$2.334M
Capital Expenditures	$24.00K	-$91.00K
Free Cash Flow	$1.870M	$2.425M
YoY Change	214.29%	-857.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	118000	usd
	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	89000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21449	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19659	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6313000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6257000
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5645000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5589000
CY2022Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2022Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2022Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	394000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-97000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	36000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	787000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-396000	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1000
	dei	Document Type DocumentType	10-Q
	us-gaap	Net Income Loss NetIncomeLoss	-396000	usd
	us-gaap	Net Income Loss NetIncomeLoss	956000	usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-13738
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	58-1701987
	dei	Entity Address Address Line1 EntityAddressAddressLine1	289 Great Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Acton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01720
	dei	City Area Code CityAreaCode	978
	dei	Local Phone Number LocalPhoneNumber	206-8220
	dei	Security12b Title Security12bTitle	Common stock. $0.005 par value
	dei	Trading Symbol TradingSymbol	PMD
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5644696
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3458000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1992000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4953000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4116000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1510000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1499000	usd
CY2022Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	803000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2678000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	10724000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	10285000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5064000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6691000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	843000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	864000	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	935000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	160000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2912000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3552000	usd
CY2022Q3	us-gaap	Assets Assets	20478000	usd
CY2021Q4	us-gaap	Assets Assets	21552000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	857000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	994000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3974000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3188000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	360000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	664000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	985000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	984000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6176000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5830000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	380000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	599000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2200000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2880000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	8756000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	9309000	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	32000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	31000	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	34139000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	33478000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10733000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9550000	usd
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	11722000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12243000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20478000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21552000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6516000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6673000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19537000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18473000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4184000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3598000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12492000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10394000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	2332000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	3075000	usd
	us-gaap	Gross Profit GrossProfit	7045000	usd
	us-gaap	Gross Profit GrossProfit	8079000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1588000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1329000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4360000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4138000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	791000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	652000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2409000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1950000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	328000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	244000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1003000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	817000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2707000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2225000	usd
	us-gaap	Operating Expenses OperatingExpenses	7772000	usd
	us-gaap	Operating Expenses OperatingExpenses	6905000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-375000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	850000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-727000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1174000	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2181000	usd
	us-gaap	Net Income Loss NetIncomeLoss	956000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-678000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1236000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-286000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	186000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-282000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	280000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-97000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	739000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-396000	usd
	us-gaap	Net Income Loss NetIncomeLoss	956000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2181000	usd
CY2022Q3	pmd	Other Nonoperating Expense Settlement OtherNonoperatingExpenseSettlement	-0	usd
CY2021Q3	pmd	Other Nonoperating Expense Settlement OtherNonoperatingExpenseSettlement	2075000	usd
	pmd	Other Nonoperating Expense Settlement OtherNonoperatingExpenseSettlement	-0	usd
	pmd	Other Nonoperating Expense Settlement OtherNonoperatingExpenseSettlement	2075000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-31000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	49000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-44000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	75000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	49000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	62000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-383000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	925000	usd
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.07
CY2021Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.14
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	11936000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	-0	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	277	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	11722000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12243000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	-0	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	694000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	11722000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13115000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	178000	usd
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	739000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	14027000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	12512000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	564000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	14027000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2181000	usd
	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	1836000	usd
	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	2134000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	718000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	697000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-775000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5000	usd
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	523000	usd
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	515000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	787000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	-0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1342000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-520000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	36000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	79000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	694000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	564000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	837000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1325000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1840000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1875000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-226000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-137000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-129000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-757000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-754000	usd
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	786000	usd
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	1422000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2996000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-151000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	60000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	68000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	103000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	84000	usd
	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	25000	usd
	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	42000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-188000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-194000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1466000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-865000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1992000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2833000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3458000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1968000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	10000	usd
	us-gaap	Interest Paid Net InterestPaidNet	36000	usd
	us-gaap	Interest Paid Net InterestPaidNet	40000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	849000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	862000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	78000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	193000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	564000	usd
CY2021Q3	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	1000000.0	usd
	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	2600000	usd
CY2022Q3	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	1900000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3500000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	277000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	178000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	694000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	574000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.23
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.07
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.07
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	572000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.28
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y3M18D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	74000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	519000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.89
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5542000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M6D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	21000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5638000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5613000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5542000
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	84000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	72000
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5638000
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5626000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5613000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5614000
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	773000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	605000
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2900000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3200000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	262000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	762000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19537000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18473000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	238000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1133000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1061000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	553000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	460000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3445000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	260000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3185000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	985000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2200000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3185000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6516000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6673000	usd

Files In Submission

Name	View Source	Status
0001171843-22-007389-index-headers.html	Edgar Link	pending
0001171843-22-007389-index.html	Edgar Link	pending
0001171843-22-007389.txt	Edgar Link	pending
0001171843-22-007389-xbrl.zip	Edgar Link	pending
ex_440378.htm	Edgar Link	pending
ex_440379.htm	Edgar Link	pending
ex_440380.htm	Edgar Link	pending
ex_440381.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pmd-20220930.xsd	Edgar Link	pending
pmd20220930_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pmd-20220930_def.xml	Edgar Link	unprocessable
pmd-20220930_lab.xml	Edgar Link	unprocessable
pmd-20220930_pre.xml	Edgar Link	unprocessable
pmd20220930_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
pmd-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMDI
PSYCHEMEDICS CORP Stock $pmdi

2022 Q4 Form 10-Q Financial Statement

#000117184322007389 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI PSYCHEMEDICS CORP Stock $pmdi

2022 Q4 Form 10-Q Financial Statement

#000117184322007389 Filed on November 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI
PSYCHEMEDICS CORP Stock $pmdi